The LabCentral Golden Ticket offers early-stage biotech innovators a year of free lab space in Boston to accelerate breakthrough scientific research, sponsored by Roche and Genentech.
Funder: Roche
Due Dates (Anticipated): April 2027 (application deadline, projected)
Funding Amounts: One year of free lab space at LabCentral in Boston; no direct cash award.
Summary: Provides innovative biotech startups and researchers with one free year of lab space at LabCentral, Boston, to accelerate scientific discovery and foster partnerships.
The LabCentral Golden Ticket is a unique opportunity designed to support early-stage biotech startups and researchers by providing one year of free lab space at LabCentral, a premier shared laboratory facility in Boston. Sponsored by Roche and Genentech, this award aims to accelerate innovative research, foster a collaborative scientific community, and help recipients access state-of-the-art resources. The program is intended to catalyze scientific discovery and the development of breakthrough medicines and technologies by removing barriers to high-quality lab infrastructure for promising biotech ventures.